Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dimetofrine is a synthetic sympathomimetic amine structurally related to phenylephrine. It acts primarily as a cardiac stimulant and vasopressor by directly stimulating beta-adrenergic receptor in the heart and blood vessels. This leads to increased cardiac output and elevated blood pressure. Dimetofrine has been used in the management of hypotension (low blood pressure), particularly orthostatic hypotension and shock states. Its mechanism of action involves direct agonism at beta-adrenergic receptor, resulting in positive inotropic (increased force of contraction) and chronotropic (increased heart rate) effects on the myocardium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dimetofrine.